0000000001243122

AUTHOR

Sandra García-esteban

showing 2 related works from this author

Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2

2021

AbstractMost public health measures to contain the COVID-19 pandemic are based on preventing the pathogen spread, and the use of oral antiseptics has been proposed as a strategy to reduce transmission risk. The aim of this manuscript is to test the efficacy of mouthwashes to reduce salivary viral load in vivo. This is a multi-centre, blinded, parallel-group, placebo-controlled randomised clinical trial that tests the effect of four mouthwashes (cetylpyridinium chloride, chlorhexidine, povidone-iodine and hydrogen peroxide) in SARS-CoV-2 salivary load measured by qPCR at baseline and 30, 60 and 120 min after the mouthrinse. A fifth group of patients used distilled water mouthrinse as a contr…

AdultMaleAdolescentScienceMouthwashesArticleMalalties transmissibles PrevencióYoung AdultDouble-Blind Methodstomatognathic systemHumansChildSalivaAgedMultidisciplinarySARS-CoV-2QRInfant NewbornCOVID-19InfantMiddle AgedViral LoadPlacebo EffectVirusViral infectionChild PreschoolRandomized controlled trialsAnti-Infective Agents LocalMedicineFemale
researchProduct

Retrospective screening for SARS-CoV-2 among influenza-like illness hospitalizations: 2018-2019 and 2019-2020 seasons, Valencia region, Spain

2021

Este artículo se encuentra disponible en la siguiente URL: https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.12899 En este artículo de investigación también participan: Juan Mollar-Maseres, Germán Schwarz-Chavarri, Sandra García-Esteban, Joan Puig-Barberà, Javier Díez-Domingo y F. Xavier López-Labrador. On 9 March 2020, the World Health Organization (WHO) Global Influenza Programme (GIP) asked participant sites on the Global Influenza Hospital Surveillance Network (GIHSN) to contribute to data collection concerning severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We re-analysed 5833 viral RNA archived samples collected prospectively from hospital admissions for influenza-lik…

Pulmonary and Respiratory Medicinemedicine.medical_specialty2019-20 coronavirus outbreakRT‐PCRSARS-CoV-2 (Virus) - Diagnóstico - 2018-2019 - España - Valencia (Comunidad Valenciana)EpidemiologyShort CommunicationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationShort CommunicationscoronavirusData analysis.COVID-19 - Diagnóstico - 2019-2020 - España - Valencia (Comunidad Autónoma)medicine.disease_causeWorld healthCOVID‐19Influenza HumanPandemicmedicineHumansCOVID-19 - Diagnóstico - 2018-2019 - España - Valencia (Comunidad Autónoma)Influenza - Diagnosis - 2019-2020 - Spain - Valencia (Autonomous Community)Viral rnaGripe - Diagnóstico - 2018-2019 - España - Valencia (Comunidad Autónoma)influenza‐like‐illnesseducationRetrospective StudiesCoronaviruseducation.field_of_studyInfluenza-like illnessSARS-CoV-2business.industrySARS-CoV-2 (Virus) - Diagnosis - 2018-2019 - Spain - Valencia (Autonomous Community)COVID-19 (Disease) - Diagnosis - 2019-2020 - Spain - Valencia (Autonomous Community)Public Health Environmental and Occupational HealthCOVID-19virus diseasesCOVID-19 (Disease) - Diagnosis - 2018-2019 - Spain - Valencia (Autonomous Community)Análisis de datos.HospitalizationSARS-CoV-2 (Virus) - Diagnóstico - 2019-2020 - España - Valencia (Comunidad Valenciana)Infectious DiseasesInfluenza - Diagnosis - 2018-2019 - Spain - Valencia (Autonomous Community)SpainGripe - Diagnóstico - 2019-2020 - España - Valencia (Comunidad Autónoma)Emergency medicineSARS-CoV-2 (Virus) - Diagnosis - 2019-2020 - Spain - Valencia (Autonomous Community)Seasonsbusiness
researchProduct